The National Cancer Centre Singapore, part of SingHealth, has begun implementing Altera Digital Health's Sunrise Oncology electronic medical record (EMR) solution. This solution, offers clinician tools such as decision support during prescribing and real-time analysis of treatment efficacy and outcomes.
The implementation is part of SingHealth's larger e-chemotherapy project aimed at creating a paperless electronic oncology workflow across multiple institutions. Sunrise Oncology will support workflows for solid tumours and blood cancers, integrating seamlessly with other Sunrise modules. SingHealth has been utilising Altera's healthcare solutions since 1998 and extended the agreement until 2029. The implementation aligns with the opening of NCCS's new building, which expands cancer care, research, rehabilitation, and education facilities.
The integration of Sunrise Oncology improves patient data accessibility, safety, and continuity of care across SingHealth institutions. The flexibility of the Sunrise solution allows for customised tools and standardised care, enabling patients to transition seamlessly between different care centers.
"The flexibility of the Sunrise solution has enabled SingHealth to develop and build on the platform to deploy customised tools alongside a wide range of oncology protocol regimes. This ensures high-quality and standardised care, where patients can seamlessly move from inpatient care to outpatient care and vice versa," said Todd Haebich, EVP, APAC, Altera.
Click here to read the original news story.